Using our AI model trained on historical data, we generated a 12‑month forecast for Revolution Medicines Inc. (RVMD) stock. The model estimates a median target price of 62.41—ranging from a low of 51.29 to a high of 73.6—which suggests an increase of 62.91% compared to the current price of 38.31.